Melanoma
Figure 1: The most commonly mutated genes in melanoma in the AACR Project GENIE® Registry in release 12.0-public Figure...
Figure 1: The most commonly mutated genes in prostate cancer in the AACR Project GENIE® Registry in release 12.0-public...
Believe in Progress features conversations with cancer survivors, patient advocates, and leading researchers and physician-scientists. Hosted by Mitch Stoller,...
Tailored RWD Solutions AACR Project GENIE® offers customized real-world data solutions to meet the specific needs of partners. Retrospective...
Even before the announcement of the National Cancer Moonshot Initiative, the AACR provided thought leadership to the White House...
Supporting the Complete Life Cycle of Research As part of its mission to prevent and cure cancer, the American...
The AACR Project GENIE® Consortium consists of 20 leading international cancer centers, dedicated to collaborative data sharing and precision...
The following narrative describes over 100 years of AACR history. From the simple beginning of a few scientists gathering...
The American Association for Cancer Research (AACR) takes great care in placing your donation where it truly belongs: in...
Researchers at the AACR Annual Meeting 2024 shared how AACR Project GENIE data is helping their studies.
Members of the AACR Project GENIE consortium presented their first analyses of the data during the Pan-Cancer Genomic Analysis...
The term “cancer” encompasses a broad range of diseases that can afflict almost any organ of the body. Not only do molecular features...
AACR Project Genomics Evidence Neoplasia Information Exchange, or GENIE for short, has released one of the largest fully public...
The unrestrained cellular proliferation that characterizes cancer largely arises due to genetic mutations, which can impede the regulatory mechanisms that control when and how often a cell divides. Genetic mutations may also...
The AACR Project Genomics Evidence Neoplasia Information Exchange (AACR Project GENIE) is a unique registry that aggregates, harmonizes, and...
When creating anything new, one must ask the question, “will others use it?” A driving force behind the creation...
Guest post by the Biopharma Collaborative Core Team In 2019, AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) embarked...
AACR Project Genomics Evidence Neoplasia Information Exchange (GENIE) recently hit another milestone: the public release of a fourth dataset,...
At the AACR Annual Meeting 2025, researchers shared how AACR Project GENIE is helping provide insights into rare and...
Guest Post by Charles L. Sawyers, MD AACR Project GENIE Steering Committee Chairperson
The term “hackathon” may conjure up images of beanie-wearing coders working in dark basements, trying to build a new...
The American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) recently received funding from Genentech...
Cancer health disparities are driven by the compounding of multiple factors, including gaps in research resulting from insufficient representation...
Takeaways from day four of the AACR Annual Meeting 2025 included data on one-dose HPV vaccination, technology advancing research,...
Guest post by Jeremy Warner, MD, MS, and Deborah Doroshow, MD, PhD The world is facing a pandemic unlike...
AACR Global Scholar-in-Training Award recipients shared how the program’s professional development opportunities have impacted their careers.
Whether cures for cancer are realized through personalized medicine, cancer vaccines, immunotherapy, or a combination of these or other...
The AACR supports the mission of World Cancer Day 2024 to Close the Care Gap, which it has worked...
Last year, the U.S. Food and Drug Administration approved 15 new anticancer therapeutics. More groundbreaking treatments are on the...